1-6 of 6
Jeffery J Auletta, MD
Close
Sort by
Journal Articles

Cytomegalovirus Reactivation Does Not Increase Subsequent Risk for Acute Graft-Versus-Host Disease, Malignant Disease Relapse, or Infection Following Allogeneic Hematopoietic Cell Transplantation

Jeffery J Auletta, MD, Monica I Ardura, DO, Sumithira Vasu, MBBS, Ying Huang, MA, MS, Qiuhong Zhao, MS, Amy S. Ruppert, MAS, Abigail Shoben, PhD, Patrick Elder, MS, Anissa Bingman, MS, Rhonda Kitzler, MS, Gerard Lozanski, MD, Rolla Abu-Arja, MD, Hemalatha G. Rangarajan, MD, Rajinder Bajwa, MBBS, MD MRCP, Edwin M Horwitz, MD PhD, Lynn O'Donnell, PhD, Samantha Jaglowski, MD MPH, Rebecca B Klisovic, MD, Sam Penza, MD, Yvonne A Efebera, MD MPH, Craig C Hofmeister, Ashley E Rosko, MD, Don M Benson, MD PhD, Leslie A. Andritsos, MD, William Blum, MD, Steven M Devine, MD
Journal: Blood
Blood (2016) 128 (22): 3409.
https://doi.org/10.1182/blood.V128.22.3409.3409
Published: 2016
Journal Articles

Early Infection Attenuates Hematologic Malignant Disease Relapse Following Initial Allogeneic Hematopoietic Cell Transplantation

Jeffery J Auletta, MD, Monica I Ardura, DO, Sumithira Vasu, MBBS, Ying Huang, MA, MS, Qiuhong Zhao, MS, Amy S. Ruppert, MAS, Abigail Shoben, PhD, Patrick Elder, MS, Anissa Bingman, MS, Rhonda Kitzler, MS, Gerard Lozanski, MD, Rolla Abu-Arja, MD, Hemalatha G. Rangarajan, MD, Rajinder Bajwa, MBBS, MD MRCP, Edwin M Horwitz, MD PhD, Lynn O'Donnell, PhD, Samantha Jaglowski, MD MPH, Rebecca B Klisovic, MD, Sam Penza, MD, Yvonne A Efebera, MD MPH, Craig C Hofmeister, Ashley E Rosko, MD, Don M Benson, MD PhD, Leslie A. Andritsos, MD, William Blum, MD, Steven M Devine, MD
Journal: Blood
Blood (2016) 128 (22): 3410.
https://doi.org/10.1182/blood.V128.22.3410.3410
Published: 2016
Journal Articles

Human Mesenchymal Stem Cells Attenuate Graft- Versus -Host Disease and Maintain Graft- Versus -Leukemia in Murine Allogeneic Bone Marrow Transplantation

Jeffery J Auletta, MD, Saada Eid, BS, Matthew Keller, BS, Leland Metheny, MD, Rocio Guardia-Wolff, BS, Zhenghong Lee, PhD, Luis A Solchaga, PhD, Kenneth R. Cooke, MD
Journal: Blood
Blood (2011) 118 (21): 1907.
https://doi.org/10.1182/blood.V118.21.1907.1907
Published: 2011
Journal Articles

Toll-Like Receptor-Stimulated CD14 + Monocytes Induce Soluble Factors That Activate Human Mesenchymal Stem Cells To Inhibit T-Cell Alloreactivity.

Jeffery J. Auletta, MD, Basabi Maitra, BS, Emese Szekely, BS, Luis Solchaga, PhD
Journal: Blood
Blood (2006) 108 (11): 2564.
https://doi.org/10.1182/blood.V108.11.2564.2564
Published: 2006
Journal Articles

Toll-Like Receptor Agonists Induce Secretion of Immunomodulatory Soluble Factors from Human Mesenchymal Stem Cells.

Jeffery J. Auletta, MD, Basabi Maitra, BS, Emese Szekely, BS, Omer N. Koc, MD
Journal: Blood
Blood (2005) 106 (11): 1394.
https://doi.org/10.1182/blood.V106.11.1394.1394
Published: 2005
Journal Articles

Post-Transplant Administration of Flt3 Ligand Enhances Innate Cellular-Mediated Immune Responses to Toll-Like Receptor Agonists in Syngeneic Bone Marrow Transplant Mice.

Jeffery J. Auletta, MD, Laura Xu, MD, Jennifer L. DeVecchio, BA, Frederick P. Heinzel, MD
Journal: Blood
Blood (2005) 106 (11): 5229.
https://doi.org/10.1182/blood.V106.11.5229.5229
Published: 2005